The Company is a Korea-based company mainly engaged in the manufacturing and distribution of specialty pharmaceuticals. The company's main products include cardiovascular drugs involves hypertension and hyperlipidemia medicines, as well as blood circulation improvement drugs; analgesics for severe pain and anesthetics for surgery and sedation; as well as gastrointestinal drugs such as peptic ulcer treatment and antispasmodics. The Company also provides antibiotics, dermatology analgesics, antipyretics and anti-inflammatory drugs. The Company was founded on January 19, 1978 and its shares are listed on Korea Stock Exchange on October 02, 2018.
Headquarters
13-39, Jeyakdanji-Ro, Hyangnam-Eup, Hwaseong-Si, Gyeonggi-Do
Hwaseong; Gyeonggi;
Contact Details: Purchase the Hana Pharm Co.,Ltd. report to view the information.
Website: http://www.hanaph.co.kr
EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.
Request a demo of the EMIS serviceTo view more information, Request a demonstration of the EMIS service